Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study

Respiratory Medicine

Volumn 109, Issue 3, 2015, Pages 397-405

  Bauer, Philippe R ^a   Kalra, Sanjay ^a   Osborn, Thomas G ^a   Sauver, Jennifer St ^a   Hanson, Andrew C ^a   Schroeder, Darrell R ^a   Ryu, Jay H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antinuclear antibodies; Biomarkers; Case control study; Connective tissue disease; Interstitial lung disease

Indexed keywords

ANTINUCLEAR ANTIBODY; FRUCTOSE BISPHOSPHATE ALDOLASE; RHEUMATOID FACTOR; BIOLOGICAL MARKER; IMMUNOLOGIC FACTOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SURVIVAL RATE; TERTIARY CARE CENTER; ADVERSE EFFECTS; BLOOD; COMPARATIVE STUDY; ELECTRONIC MEDICAL RECORD SYSTEM; IMMUNOLOGY; KAPLAN MEIER METHOD; LUNG DISEASES, INTERSTITIAL; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

AGED; ANTIBODIES, ANTINUCLEAR; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; FRUCTOSE-BISPHOSPHATE ALDOLASE; HUMANS; IMMUNOLOGIC FACTORS; KAPLAN-MEIER ESTIMATE; LUNG DISEASES, INTERSTITIAL; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RHEUMATOID FACTOR; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; TERTIARY CARE CENTERS; UNITED STATES;

EID: 84933181207     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.01.011     Document Type: Article

References (37)

1. Ryu JH, Daniels CE, Hartman TE, Yi ES. Diagnosis of interstitial lung diseases. Mayo Clin Proc 2007;82(8):976-86.
2. Cottin V. Significance of connective tissue diseases features in pulmonary fibrosis. Eur Respir Rev 2013;22(129):273-80.
3. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156:528-35.
4. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297-301.
5. Fathi M, Lundberg IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2005;17:701-6.
6. Ferri C, Valentini G, Cozzi F, et al., Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Med Baltim 2002; 81:139-53.
7. Murin S, Wiedemann HP, Matthay RA. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 1998; 19:641-65.
8. Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med 2004;25(3):549-59.
9. Ryu JH, Olson EJ, Midthun DE, Swensen SJ. Diagnostic approach to the patient with diffuse lung disease. Mayo Clin Proc 2002;77:1221-7.
10. Vij R, Strek ME. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 2013;143(3):814-24.
11. Tzelepis GE, Toya SP, Moutsopoulos HM. Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 2008;31(1):11-20.
12. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011;140(5):1292-9.
13. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010;138(2):251-6.
14. Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007;176(7):691-7.
15. Fisher A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet 2012;380(9842):689-98.
16. Papiris SA, Kagouridis K, Bouros D. Serologic evaluation in idiopathic interstitial pneumonias. Curr Opin Pulm Med 2012;18(5):433-40.
17. Alhamad EH, Al-Kassimi FA, Alboukai AA, et al. Comparison of three groups of patients with usual interstitial pneumonia. Respir Med 2012;106(11):1575-85.
18. Bauer PR, Schiavo DN, Osborn TG, et al. Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study. Chest 2013;144(2):571-7.
19. American thoracic Society/European respiratory Society international multidisciplinary Consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American thoracic Society (ATS), and the European respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165(2):277-304.
20. Travis WD, Costabel U, Hansell DM, et alATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188(6):733-48.
21. Gutsche M, Rosen GD, Swigris JJ. Connective tissue diseaseassociated interstitial lung disease: a review. Curr Respir Care Rep 2012;1:224-32.
22. Mosca M, Tani C, Neri C, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 2006;6:1-4.
23. Rollin Brant. Unmatched case/control studies. http://www.stat.ubc.ca/∼rollin/stats/ssize/caco.html . Accessed online October 28, 2013.
24. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58(2):143-8.
25. de Lauretis A, Veeraraghavan S, Renzoni E. Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis 2011;8(1):53-82.
26. Kinder BW, Shariat C, Collard HR, et al. Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung 2010;188(2):143-9.
27. Suda T, Kono M, Nakamura Y, et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir Med 2010;104(10):1527-34.
28. Corte TJ, Copley SJ, Desai SR, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012;39(3):661-8.
29. Schuller E, Allinquant B, Reboul J, Fournier C, Dardenne M, Bach JF. Immunological studies in human ageing. II. Associated increase in anti-RNA and anti-DNA antibodies. J Clin Lab Immunol 1981;6(2):107-10.
30. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174(7):810-6.
31. Moua T, Maldonado F, Decker PA, Daniels CE, Ryu JH. Frequency and implication of autoimmune serologies in idiopathic pulmonary fibrosis. Mayo Clin Proc 2014;89(3):319-26.
32. Tzouvelekis A, Zacharis G, Oikonomou A, et al. Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. BMC Pulm Med 2013;13:31.
33. Wells AU, Nicholson AG, Hansell DM. Challenges in pulmonary fibrosis. 4: smoking-induced diffuse interstitial lung diseases. Thorax 2007;62(10):904-10.
34. Mukhopadhyay S, Parambil JG. Acute interstitial pneumonia (AIP): relationship to hamman-rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS). Semin Respir Crit Care Med 2012;33(5):476-85.
35. Mittoo S, Gelber AC, Christopher-Stine L, Horton MR, Lechtzin N, Danoff SK. Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med 2009;103(8):1152-8.
36. Kocheril SV, Appleton BE, Somers EC, et al. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum 2005;53(4):549-57.
37. Su R, Bennett M, Jacobs S, et al. An analysis of connective tissue disease-associated interstitial lung disease at a US tertiary care center: better survival in patients with systemic sclerosis. J Rheumatol 2011;38(4):693-701.